Direct Answer
Gastroenterology billing centers on endoscopic procedure coding — a highly structured CPT family where the specific technique, anatomical extent of examination, and additional interventions (biopsy, polyp removal, ablation) each generate distinct codes. The single most significant billing distinction in GI is colonoscopy screening vs. diagnostic, which determines patient cost-sharing, preventive benefit coverage, and the billing code used. A colonoscopy that begins as a screening but results in a polyp removal must be coded correctly to reflect both the screening intent and the therapeutic intervention, and this combination is a frequent denial trigger that requires provider-specific knowledge of payer rules.
Table of Contents
Colonoscopy Codes 45378-45398
Colonoscopy codes are organized by the examination performed and the additional procedures performed during the same session: Diagnostic/screening colonoscopy: 45378 — colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed; this is the base diagnostic colonoscopy code; Colonoscopy with biopsy: 45380 — colonoscopy, flexible; with biopsy, single or multiple; Colonoscopy with polyp removal: 45384 — colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps; 45385 — with removal of tumor(s), polyp(s), or other lesion(s) by snare technique; 45386 — with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed); 45388 — with ablation of tumor(s), polyp(s), or other lesion(s); Colonoscopy with control of bleeding: 45382 — colonoscopy, flexible; with control of bleeding, any method; Colonoscopy with stent placement: 45389 — with endoscopic stent placement (including pre- and post-dilation and guide wire passage, when performed); Colonoscopy through stoma: 45355 — colonoscopy through stoma; 45383 — with ablation; Flexible sigmoidoscopy codes: 45330 — flexible sigmoidoscopy; diagnostic; 45331 — with biopsy; 45332 — with removal of foreign body; 45333 — with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps; 45338 — with removal of tumor(s), polyp(s), or other lesion(s) by snare technique; Screening vs. diagnostic colonoscopy distinction: this is the critical billing distinction in GI; screening colonoscopy: performed on an asymptomatic patient for cancer prevention and detection; covered as a preventive service with no patient cost-sharing for Medicare patients under APC 0152; diagnosis code Z12.11 (encounter for screening for malignant neoplasm of colon); diagnostic colonoscopy: performed for a symptomatic patient (rectal bleeding, change in bowel habits, positive FIT/FOBT, follow-up of prior polyp); patient cost-sharing applies; different diagnosis codes; Screening colonoscopy with polyp removal: when a screening colonoscopy is converted to therapeutic due to polyp removal, many payers now cover the procedure as preventive (no patient cost-sharing) per the ACA; however, the billing code changes from 45378 to the appropriate polyp removal code (45385, etc.); some payers still apply cost-sharing when the code changes; documentation must reflect the preventive intent with therapeutic finding.
Upper GI Endoscopy (EGD) Codes
Esophagogastroduodenoscopy (EGD) codes parallel the colonoscopy structure but address the upper GI tract: Diagnostic EGD: 43239 — esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple; note: 43235 (diagnostic EGD without biopsy) is less commonly billed separately since biopsies are taken in almost all EGDs; EGD with additional procedures: 43236 — with directed submucosal injection(s), any substance; 43237 — with endoscopic ultrasound examination limited to the esophagus, stomach or duodenum, and adjacent structures; 43238 — with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(ies); 43239 — with biopsy; 43240 — with transmural drainage of pseudocyst; 43245 — with dilation of gastric outlet for obstruction; 43247 — with removal of foreign body(ies); 43248 — with insertion of guide wire followed by dilation of esophagus over guide wire; 43249 — with transendoscopic balloon dilation of esophagus less than 30mm diameter; 43250 — with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps; 43251 — with removal of tumor(s), polyp(s), or other lesion(s) by snare technique; 43254 — with endoscopic mucosal resection; 43255 — with control of bleeding, any method; 43266 — with placement of enteral stent; Esophagoscopy (separate from EGD): 43191 — esophagoscopy, rigid or flexible, transoral; diagnostic; 43197 — esophagoscopy, flexible, transnasal; diagnostic; 43200 — esophagoscopy, flexible, transoral; with biopsy; POEM (peroral endoscopic myotomy): 43497 — lower esophageal myotomy, per oral (POEM procedure); this is a newer high-complexity code for achalasia treatment; Prior authorization is typically required.
ERCP Codes 43260-43278
Endoscopic retrograde cholangiopancreatography (ERCP) codes are highly specific to the therapeutic interventions performed: ERCP base codes: 43260 — endoscopic retrograde cholangiopancreatography (ERCP); diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure); 43261 — with biopsy, single or multiple; 43262 — with sphincterotomy/papillotomy; 43263 — with pressure measurement of sphincter of Oddi; 43264 — with removal of calculi/debris from biliary/pancreatic duct(s); 43265 — with destruction of calculi, any method; 43270 — with ablation of tumor(s), polyp(s), or other lesion(s); 43272 — with ablation of tumor(s), polyp(s), or other lesion(s), transendoscopic, via brush, forceps, or other method; 43274 — with placement of endoscopic stent into biliary or pancreatic duct; 43275 — with removal of foreign body, calculus, or changing of stent (separate procedure); 43276 — with removal and exchange of stent; 43277 — with transpancreatic sphincteroplasty; 43278 — with ablation of tumor(s), polyp(s), or other lesion(s); Prior authorization for ERCP: ERCP always requires prior authorization from commercial payers; the authorization request must specify the indication (choledocholithiasis, biliary stricture, pancreatic duct pathology, etc.) and the anticipated therapeutic intervention; Interventional radiology ERCP component: ERCP includes fluoroscopic guidance; the fluoroscopy component (74300-74301) is typically bundled with the ERCP code under CMS NCCI edits; for professional billing, Modifier 26 may be used if the gastroenterologist is also interpreting the fluoroscopic images; EUS (Endoscopic Ultrasound): 43237 — EUS of esophagus/stomach/duodenum (with EGD); 43231 — esophagoscopy with EUS; 43259 — EUS of the rectum/sigmoid; 43253 — EUS-guided transmural injection.
Capsule Endoscopy and Other GI Procedures
Capsule endoscopy and motility studies represent additional GI procedure categories with distinct billing structures: Capsule endoscopy: 91110 — gastrointestinal tract imaging; intraluminal (e.g., capsule endoscopy), esophagus through ileum, with interpretation and report; 91111 — esophagus with interpretation and report; 91112 — transit and pressure measurement of the colon with wireless motility capsule; 91113 — colon imaging by capsule endoscopy, including interpretation and report; Medical necessity for capsule endoscopy: indications include obscure GI bleeding (OGIB) after negative EGD and colonoscopy, suspected Crohn's disease in the small bowel, and surveillance for familial polyposis; documentation must reflect prior negative EGD and colonoscopy; prior authorization is typically required and coverage criteria are payer-specific; GI motility studies: 91020 — gastric motility (manometric) studies; 91022 — duodenal motility (manometric) studies; 91030 — esophageal acid perfusion test; 91034 — esophagus, gastroesophageal reflux test; with nasal catheter pH electrode(s) placement, recording, analysis and interpretation; 91035 — with simultaneous pH monitoring and manometry; 91037 — esophageal function test, gastroesophageal reflux test with nasal catheter intraluminal impedance electrode(s) placement, recording, analysis and interpretation; Anorectal manometry: 91122 — anorectal manometry; BRAVO pH capsule: 91034 covers placement and interpretation; the capsule itself is billed as a supply by the facility; Liver biopsy: 47000 — biopsy of liver, needle; percutaneous; 47001 — with ultrasound guidance; 47100 — biopsy of liver, wedge; hepatic biopsy with imaging guidance: 76942 (ultrasound) or 77002 (fluoroscopic) guidance.
GI Denials and RCM
Gastroenterology billing denials center on the screening vs. diagnostic distinction, polyp removal coding, and prior authorization for advanced procedures: Common GI denial patterns: screening converted to diagnostic — patient cost-sharing surprise: when a screening colonoscopy results in polyp removal and the code changes from 45378 to 45385, some payers apply cost-sharing that the patient didn't expect; the ACA requires that screening colonoscopies that become therapeutic (polyp removal) remain cost-sharing free for plans required to comply; Medicare has implemented this policy; however, implementation varies; practices must understand each payer's policy before quoting patient cost at scheduling; NCCI bundling of biopsy and polyp removal codes: billing both 45380 (biopsy) and 45385 (snare polypectomy) for different lesions in the same session is appropriate and allowed; NCCI edits allow multiple techniques when performed on separate lesions with appropriate documentation; the operative report must clearly document separate lesions and the technique used for each; multiple polyp coding: only the most significant procedure is billed per anatomical site; if multiple polyps are removed by different techniques (hot biopsy forceps for one, snare for another), each distinct technique may be billed if documentation supports separate lesions and interventions; missing PA for ERCP and capsule endoscopy: these advanced procedures require prior authorization; GI RCM best practices: screening/diagnostic classification at scheduling: the scheduling staff must correctly classify the colonoscopy indication at scheduling to set patient expectations for cost-sharing; the classification may change if the clinical encounter reveals symptoms; update the diagnosis at the time of the procedure; procedure note documentation for endoscopy: the endoscopy report must document: scope advancement extent (cecum reached or ileum for colonoscopy); all lesions identified (size, location, characteristics); technique used for each intervention; specimen disposition; instrument withdrawal time (quality metric).
FAQ
How should a colonoscopy be billed when a patient has a personal history of colon cancer — as screening or diagnostic?
This is one of the most common billing questions in gastroenterology because the answer affects patient cost-sharing significantly and varies by payer: Personal history of colon cancer — diagnostic, not screening: a patient with a personal history of colorectal cancer (ICD-10 Z85.038) is not an average-risk screening patient; colonoscopy for surveillance in a patient with personal history of colorectal cancer is a diagnostic/surveillance procedure, not a preventive screening; the appropriate diagnosis code is Z85.038 (personal history of malignant neoplasm of large intestine) or Z12.11 if screening intent is documented; Medicare: CMS specifically classifies surveillance colonoscopy for personal history of polyps or colon cancer as a diagnostic procedure; patient pays standard cost-sharing (20% after deductible for Medicare); Commercial payer variation: some commercial payers under ACA-compliant plans categorize surveillance colonoscopy (even for patients with personal history) as a preventive service covered without cost-sharing; this is payer-specific and plan-specific; verify the specific payer's policy before quoting patient cost; Family history vs. personal history: a patient with family history of colon cancer but no personal history is an increased-risk screening patient; colonoscopy may be covered as preventive screening under ACA preventive benefit rules but at an earlier age and/or shorter interval than average-risk screening; diagnosis code Z80.0 (family history of malignant neoplasm of digestive organs); Documentation best practice: the endoscopy report and the claim diagnosis must accurately reflect the clinical indication; billing Z12.11 (screening) for a patient with personal history of colon cancer when the true indication is surveillance is a claim misrepresentation; always code the actual clinical indication.
What is the correct billing approach when an EGD and colonoscopy are performed in the same session?
When a gastroenterologist performs both an EGD and a colonoscopy in the same operative session, both procedures are separately billable — they are distinct procedures involving different anatomical regions and separate instruments: Billing both procedures: bill the appropriate EGD code (43235-43259) and the appropriate colonoscopy code (45378-45398) for the same date of service; both codes represent complete, distinct procedures and are not bundled under NCCI edits; Multiple procedure reduction: Medicare and most commercial payers apply a multiple procedure reduction: the higher-valued procedure is paid at 100%; the second procedure is paid at 50% of the fee schedule amount (or as specified by the payer's multiple procedure policy); Modifier 51: Modifier 51 (multiple procedures) is typically appended to the second (lower-valued) procedure code to communicate that multiple procedures were performed in the same session; some payers apply the reduction automatically without requiring Modifier 51; Anesthesia for combined EGD and colonoscopy: the anesthesiologist bills for the combined time of both procedures; propofol (MAC) anesthesia for combined EGD and colonoscopy is common in high-volume GI centers; the anesthesiologist bills 00810 (anesthesia for lower intestinal endoscopic procedures) or 00731 (for upper GI) depending on which procedure drove anesthesia complexity; typically the highest-base-value anesthesia code is billed once for the combined session; Patient positioning and scope changes: the operative report must document that both procedures were performed as distinct interventions; the typical sequence is EGD first (patient supine or in left lateral decubitus), then colonoscopy (patient repositioned); the documentation should reflect the scope change and repositioning.
Gastroenterology Revenue Cycle Management That Maximizes Endoscopy Reimbursement
Valiant Lifecare's GI billing specialists manage colonoscopy screening vs. diagnostic classification, polyp removal code selection with NCCI compliance, ERCP and capsule endoscopy prior authorization, EGD add-on procedure coding, GI motility study billing, and the full spectrum of gastroenterology denial prevention and patient cost-sharing accuracy.
Optimize Your GI Revenue Cycle